迈诺威

Minova Biopharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for dermatology, psychiatry, and aesthetic medicine. Founded in 2021 and headquartered in Suzhou, China, the company utilizes its proprietary drug delivery and formulation platforms to create differentiated therapeutic products. Its pipeline features several mid-stage programs, including treatments for androgenetic alopecia, atopic dermatitis, and localized fat reduction. Minova has successfully raised significant capital from top-tier investors like Sequoia China and Hillhouse Capital to accelerate its clinical programs. The company aims to become a leader in specialized medical fields by addressing high-growth markets with significant unmet needs.